Additional European Equity News
AstraZeneca (AZN LN) - AstraZeneca’s Trixeo Aerosphere approved in UK as first inhaled respiratory medicine using next-generation propellant with near-zero global warming potential. (Newswires)
Capita (CPI LN) - Secures three-year extension to PCSE extension. (Newswires)
IG (IGG LN) - Expects FY25 Total Revenue and Adj. PBT to meet or slightly exceed the upper end of current range of consensus. Refinances GBP 400mln credit facility with GBP 600mln facility. (Newswires)
Novo Nordisk (NOVOB DC) - Once-weekly Sogroya (somapacitan) is an efficacious and well-tolerated long-acting growth hormone in children with growth disorders. Results from REAL8 Phase 3 basket study presented at the joint congress of ESPE and ESE. Turner syndrome sub-study results expected later this year. REAL8 trial achieved its primary endpoints for first three sub-studies. (Newswires)
AB InBev (ABI BB) upgraded to Buy from Neutral at Goldman Sachs
Sandvik (SAND SS) upgraded to Overweight from Equal Weight at Morgan Stanley
12 May 2025 - 07:02- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts